François Lefrère

9.0k total citations · 1 hit paper
79 papers, 2.9k citations indexed

About

François Lefrère is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, François Lefrère has authored 79 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 28 papers in Genetics and 27 papers in Pathology and Forensic Medicine. Recurrent topics in François Lefrère's work include Hematopoietic Stem Cell Transplantation (18 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Platelet Disorders and Treatments (17 papers). François Lefrère is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Platelet Disorders and Treatments (17 papers). François Lefrère collaborates with scholars based in France, United States and Netherlands. François Lefrère's co-authors include Olivier Hermine, Bruno Varet, Françoise Valensi, Xavier Troussard, Xavier Mariette, P. Cacoub, Katayoun Jondeau, Christian Bréchot, Jean–Pierre Bronowicki and Virginie Eclache-Saudreau and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

François Lefrère

78 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection

2002 554 citations Olivier Hermine, François Lefrère et al. profile →

Peers

Countries citing papers authored by François Lefrère

Since Specialization

Citations

This map shows the geographic impact of François Lefrère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Lefrère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Lefrère more than expected).

Fields of papers citing papers by François Lefrère

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Lefrère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Lefrère. The network helps show where François Lefrère may publish in the future.

Co-authorship network of co-authors of François Lefrère

This figure shows the co-authorship network connecting the top 25 collaborators of François Lefrère. A scholar is included among the top collaborators of François Lefrère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Lefrère. François Lefrère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy 2021 ·Transfusion ·Jean‐Sébastien Diana, Sandra Manceau, Thierry Leblanc, Alessandra Magnani, Elisa Magrin, Matthieu Bendavid, (unknown), Laure Joseph, Jean Soulier, Marina Cavazzana, François Lefrère	4
2	Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed 2020 ·Blood Advances ·(unknown), (unknown), Sylvain Cuvellier, Nadia Boussetta, Jean‐Christophe Deschemin, Didier Borderie, Sabine Bailly, Joël Poupon, (unknown), Jamel El‐Benna, Sandra Manceau, François Lefrère, Sophie Vaulont, Carole Peyssonnaux	21
3	Vascular access for optimal hematopoietic stem cell collection 2020 ·Journal of Clinical Apheresis ·(unknown), Sandra Manceau, Jean‐Sébastien Diana, Laure Joseph, Alessandra Magnani, Elisa Magrin, (unknown), (unknown), Jean‐Herlé Raphalen, David Sibon, Ambroise Marçais, Felipe Suárez, Marina Cavazzana, François Lefrère, Marianne Delville	9
4	Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype 2018 ·Haematologica ·Frédéric Baron, Marian Stevens‐Kroef, Michal Kiciński, Giovanna Meloni, Petra Muus, Jean‐Pierre Marie, Constantijn J.M. Halkes, Xavier Thomas, Radovan Vrḫovac, Francesco Albano, François Lefrère, Simona Sica, Marco Mancini, Adriano Venditti, Anne Hagemeijer, Joop H. Jansen, Sergio Amadori, Théo de Witte, R. Willemze, Stefan Suciu	7
5	Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome 2016 ·Haematologica ·Lamiae Grimaldi‐Bensouda, Clémentine Nordon, Marc Michel, (unknown), (unknown), N. Magy‐Bertrand, J.M. Durand, Philippe Quittet, O. Fain, Bernard Bonnotte, (unknown), (unknown), N. Costedoat‐Chalumeau, Brigitte Pan‐Petesch, Mehdi Khellaf, Antoinette Perlat, Karim Sacré, François Lefrère, Lucien Abenhaim, B. Godeau, (unknown)	58
6	CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte 2012 ·Blood ·Richard Delarue, Corinne Haïoun, Vincent Ribrag, Pauline Brice, Alain Delmer, Hervé Tilly, Gilles Salles, Achiel Van Hoof, Olivier Casasnovas, Nicole Brousse, François Lefrère, Olivier Hermine	188
7	Échanges plasmatiques thérapeutiques : procédés et indications 2012 ·François Lefrère	1
8	PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France 2011 ·Value in Health ·Laurent Chiche, François Lefrère, (unknown), Allison Perrin, Lori Stern, Martin Bischof, Saul L. Cohen	5
9	A systematic review of available clinical evidence – filgrastim compared with lenograstim 2011 ·International Journal of Clinical Pharmacology and Therapeutics ·Hildegard Sourgens, François Lefrère	21
10	First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor 2011 ·Advances in Therapy ·François Lefrère, (unknown), Caroline Elie, Jean‐Antoine Ribeil, Michael Bernimoulin, (unknown), Liliane Dal Cortivo, Richard Delarue, Olivier Hermine, Marina Cavazzana	50
11	Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft 2010 ·Transfusion ·Hélène Trebeden‐Negre, Michèlle Rosenzwajg, Marie‐Laure Tanguy, François Lefrère, Nabih Azar, Farhad Heshmati, Ramdane Belhocine, Jean‐Paul Vernant, David Klatzmann, Françoise Norol	24
12	Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study 2008 ·Blood ·Bertrand Godeau, Raphaël Porcher, Olivier Fain, François Lefrère, Pierre Fenaux, Stéphane Chèze, Anne Vekhoff, Marie‐Paule Chauveheid, Jérôme Stirnemann, Lionel Galicier, Emmanuelle Bourgeois, Stéphanie Haïat, Bruno Varet, M Leporrier, T. Papo, Mehdi Khellaf, Marc Michel, Philippe Bierling	184
13	Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis 2007 ·Transfusion ·François Lefrère, Sarah Zohar, (unknown), (unknown), Jean‐Antoine Ribeil, David Ghez, Bruno Varet, Marina Cavazzana, Liliane Dal Cortivo, Rémi Letestu, (unknown), Chantal Brouzes	29
14	Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring 2006 ·Leukemia & lymphoma ·Rémi Letestu, Christophe Marzac, (unknown), Ramdane Belhocine, (unknown), Véronique Baccini, Loïc Garçon, Liliane Dal Cortivo, Jean‐Yves Perrot, François Lefrère, Françoise Valensi, Florence Ajchenbaum‐Cymbalista	27
15	An open‐label, unit dose‐finding study of AMG 531, a novel thrombopoiesis‐stimulating peptibody, in patients with immune thrombocytopenic purpura 2006 ·British Journal of Haematology ·Adrian C. Newland, Marie Thérèse Caulier, M. C. Kappers‐Klunne, Martin R. Schipperus, François Lefrère, Jaap Jan Zwaginga, (unknown), Chien‐Feng Chen, Janet L. Nichol	115
16	Fas Ligand–Mediated Lethal Hepatitis After Rapid Lysis of a Localized Natural Killer Cell Lymphoma 2006 ·Clinical Lymphoma & Myeloma ·David Ghez, Diane Damotte, Susan P. Perrine, Douglas V. Faller, D. Canioni, Nicole Brousse, François Lefrère, Bruno Varet, Olivier Hermine	3
17	Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review 2003 ·Annals of Oncology ·Gandhi Damaj, Virginie Verkarre, Alain Delmer, Philippe Solal‐Céligny, Ibrahim Yakoub‐Agha, Christophe Cellier, (unknown), Réda Bouabdallah, V. Leblond, François Lefrère, Didier Bouscary, Josée Audouin, Bertrand Coiffier, Bruno Varet, Thierry Jo Molina, Nicole Brousse, Olivier Hermine	106
18	Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial 2002 ·The Lancet ·Bertrand Godeau, Sylvie Chevret, Bruno Varet, François Lefrère, Jean‐Marc Zini, (unknown), Stéphane Chèze, Éric Legouffe, Cyrille Hulin, Marie‐José Grange, Olivier Fain, Philippe Bierling	189
19	Comparison of Lenograstim vs Filgrastim Administration following Chemotherapy for Peripheral Blood Stem Cell (PBSC) Collection: A Retrospective Study of 126 Patients 1999 ·Leukemia & lymphoma ·François Lefrère, Marc Bernard, (unknown), Marina Cavazzana, Coralie Bélanger, Olivier Hermine, Bertrand Arnulf, Agnès Buzyn, Bruno Varet	21
20	Full or Partial Seroreversion in Patients Infected by Hepatitis C Virus 1997 ·The Journal of Infectious Diseases ·J.‐J. Lefrère, (unknown), François Lefrère, Martine Mariotti, Pascale Aumont, Joëlle Lerable, Jean‐Claude Petit, Robert Girot, Laurence Morand‐Joubert	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact